Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BRIEF-Kedrion Biopharma Announces The Extension Of A U.S. Agreement With Grifols To Support Long-Term And Continued Access To Gammaked®

BRIEF-Kedrion Biopharma Announces The Extension Of A U.S. Agreement With Grifols To Support Long-Term And Continued Access To Gammaked®

ReutersReuters2026/08/18 12:02
By:Reuters

Grifols, S.A. GRLS.MC:

  • KEDRION BIOPHARMA ANNOUNCES THE EXTENSION OF A U.S. AGREEMENT WITH GRIFOLS TO SUPPORT LONG-TERM AND CONTINUED ACCESS TO GAMMAKED®

  • KEDRION BIOPHARMA: DEAL MAINTAINS KEY THERAPIES WITHIN KEDRION'S U.S. IMMUNODEFICIENCY AND AUTO IMMUNE DISORDERS PORTFOLIO

Source text: ID:nPn32hylKa

Further company coverage: GRLS.MC


0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!